[Indication and experience with an intravenously administered aldosterone-antagonist (soldactone) (author's transl)].
D001929:Brain Edema / Q000188:drug therapy; D002191:Canrenoic Acid / Q000627:therapeutic use*; D004341:Drug Evaluation; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy; D000451:Mineralocorticoid Receptor Antagonists; D011245:Pregnadienes / Q000627:therapeutic use*; D012131:Respiratory Insufficiency / Q000188:drug therapy*
D000451:Mineralocorticoid Receptor Antagonists; D011245:Pregnadienes; D002191:Canrenoic Acid
Indikationen und Erfahrungen mit einem intravenös applizierten Aldosteron- Antagonisten (Soldactone)